Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Comparative Studies

CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer

Vol. 89 No. 9 (2004): September, 2004

Abstract

We assessed the effect of CD34+ cell dose on costs in breast cancer patients undergoing autologous peripheral blood stem cell (PBSC) transplantation. Mean hospitalization costs were 26,992.9+/-9582.9 for patients receiving a CD34+ cell dose <5 x 10(6) cells/kg versus 22,339.4+/- 5471.1 for those receiving >5 x 10(6) CD34+ cells/kg (p=0.0065).

Figures & Tables

Article Information

Vol. 89 No. 9 (2004): September, 2004 : Comparative Studies
 
 
Published
2004-01-01
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 

Article Usage

Online Views
114
PDF Downloads
69

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2024 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online